BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 12822169)

  • 1. Large left atrial thrombus formation despite warfarin therapy after device closure of a patent foramen ovale.
    Cetta F; Arruda MJ; Graham LC
    Catheter Cardiovasc Interv; 2003 Jul; 59(3):396-8. PubMed ID: 12822169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors and clinical outcomes of residual shunt in patients undergoing percutaneous transcatheter closure of patent foramen ovale.
    Zajarias A; Thanigaraj S; Lasala J; Perez J
    J Invasive Cardiol; 2006 Nov; 18(11):533-7. PubMed ID: 17090816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients.
    Krumsdorf U; Ostermayer S; Billinger K; Trepels T; Zadan E; Horvath K; Sievert H
    J Am Coll Cardiol; 2004 Jan; 43(2):302-9. PubMed ID: 14736453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Removal of a left atrial thrombus adherent to a patent foramen ovale occluder.
    Krieg P; Lapp H; Pethig K; Gummert JF; Bossert T
    Ann Thorac Surg; 2007 Apr; 83(4):1539-41. PubMed ID: 17383381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Entrapment of right atrial pacemaker lead by patent foramen ovale closure device: successful percutaneous salvage.
    Meltser H; Hoyer MH; Kalaria VG
    Catheter Cardiovasc Interv; 2005 Aug; 65(4):593-6. PubMed ID: 15937955
    [No Abstract]   [Full Text] [Related]  

  • 6. Transcatheter closure of patent foramen ovale in patients with platypnea-orthodeoxia: results of a multicentric French registry.
    Guérin P; Lambert V; Godart F; Legendre A; Petit J; Bourlon F; De Geeter B; Petit A; Monrozier B; Rossignol AM; Jimenez M; Crochet D; Choussat A; Rey C; Losay J
    Cardiovasc Intervent Radiol; 2005; 28(2):164-8. PubMed ID: 15719178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcatheter closure of atrial septal defect or patent foramen ovale with the buttoned device for prevention of recurrence of paradoxic embolism.
    Ende DJ; Chopra PS; Rao PS
    Am J Cardiol; 1996 Jul; 78(2):233-6. PubMed ID: 8712152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Late complications of percutaneous closure of atrial septal defects with the Sideris occluder].
    Lambert V; Losay J; Piot JD; Chevalier B; Bourdin T; Mace L; Angel C; Brenot P; Neveux JY
    Arch Mal Coeur Vaiss; 1997 Feb; 90(2):245-51. PubMed ID: 9181034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcatheter closure of atrial septal defect and patent foramen ovale in adult patients using the Amplatzer occlusion device: no evidence for thrombus deposition with antiplatelet agents.
    Brandt RR; Neumann T; Neuzner J; Rau M; Faude I; Hamm CW
    J Am Soc Echocardiogr; 2002 Oct; 15(10 Pt 1):1094-8. PubMed ID: 12373252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcatheter Amplatzer device closure of atrial septal defect and patent foramen ovale in patients with presumed paradoxical embolism.
    Khositseth A; Cabalka AK; Sweeney JP; Fortuin FD; Reeder GS; Connolly HM; Hagler DJ
    Mayo Clin Proc; 2004 Jan; 79(1):35-41. PubMed ID: 14708946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracardiac echocardiographic guidance during transcatheter device closure of atrial septal defect and patent foramen ovale.
    Earing MG; Cabalka AK; Seward JB; Bruce CJ; Reeder GS; Hagler DJ
    Mayo Clin Proc; 2004 Jan; 79(1):24-34. PubMed ID: 14708945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous left atrial thrombus during patent foramen ovale closure.
    Hudsmith L; Thorne S; Clift P
    Eur J Echocardiogr; 2008 Nov; 9(6):824. PubMed ID: 18606714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of thrombus formation on the CardioSEAL and the Amplatzer interatrial closure devices.
    Anzai H; Child J; Natterson B; Krivokapich J; Fishbein MC; Chan VK; Tobis JM
    Am J Cardiol; 2004 Feb; 93(4):426-31. PubMed ID: 14969615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transcatheter closure of atrial septal defects in adults. Practicality and safety of four different closure systems used in 102 patients].
    La Rosée K; Krause D; Becker M; Beuckelmann DJ; Deutsch HJ; Höpp HW
    Dtsch Med Wochenschr; 2001 Sep; 126(38):1030-6. PubMed ID: 11565056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcatheter closure of patent foramen ovale using the Amplatzer septal occluder to prevent recurrence of neurological decompression illness in divers.
    Walsh KP; Wilmshurst PT; Morrison WL
    Heart; 1999 Mar; 81(3):257-61. PubMed ID: 10026348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcatheter closure of fossa ovalis atrial septal defect: a single institutional experience.
    Tomar M; Radhakrishnan S; Shrivastava S
    Indian Heart J; 2006; 58(4):325-9. PubMed ID: 19039149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of balloon pull-through technique to assist in CardioSEAL device closure of patent foramen ovale.
    Chintala K; Turner DR; Leaman S; Rodriguez-Cruz E; Wynne J; Greenbaum A; Forbes TJ
    Catheter Cardiovasc Interv; 2003 Sep; 60(1):101-6. PubMed ID: 12929112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patent foramen ovale and left atrial appendage: new devices and methods for closure.
    Hein R; Bayard Y; Taaffe M; Büscheck F; Ostermayer S; Billinger K; Reschke M; Trepels T; Lissmann-Jensen H; Lang K; Römer A; Wilson N; Sievert H
    Pediatr Cardiol; 2005; 26(3):234-40. PubMed ID: 16132300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left atrial thrombus formation on a CardioSeal Septal Occlusion device in a patient with elevated factor VIII: resolution with medical therapy.
    Recto MR; Sobczyk W; Hadley T; Yeh T
    J Invasive Cardiol; 2003 Oct; 15(10):594-6. PubMed ID: 14519895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute thrombus formation on an Amplatzer device during transcatheter closure of an atrial septal defect in a patient with homozygous factor V Leiden mutation.
    Yazıcıoğlu V; Sahin M; Karaca O; Türkmen M
    Turk Kardiyol Dern Ars; 2011 Oct; 39(7):587-90. PubMed ID: 21983771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.